NCT03395353 A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder Status TERMINATED Phase PHASE3
NCT03382912 Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT03382899 Study of Pegilodecakin (LY3500518) With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT03381547 A 3-Way Crossover Study to Evaluate the Pharmacokinetics in Participants After Dosing With Pegilodecakin (LY3500518) Status COMPLETED Phase PHASE1
NCT03370276 Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT03367403 A Study of LY3002813 in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ) Status COMPLETED Phase PHASE2
NCT03367390 A Study of an Automated Insulin Delivery System in Participants With Type 1 Diabetes Mellitus (T1DM) Status COMPLETED Phase PHASE1
NCT03364309 A Study of Ixekizumab (LY2439821) in Chinese Participants With Moderate-to-Severe Plaque Psoriasis Status COMPLETED Phase PHASE3
NCT03363464 Comparative Effectiveness of Empagliflozin in the US Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03343613 A Study of LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors Status TERMINATED Phase PHASE1
NCT03341312 A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 2 Diabetes Mellitus (T2DM) Status COMPLETED Phase PHASE1
NCT03341299 A Comparative Study of LY900014 With Insulin Lispro (Humalog) in Participants With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT03339843 Multiorgan Metabolic Imaging Response Assessment of Abemaciclib Status COMPLETED Phase PHASE2
NCT03339453 A Study of Nasal Glucagon in Participants With Type 1 Diabetes Mellitus Status COMPLETED Phase PHASE1